Clinical Research Division, Brazilian National Cancer Institute (INCA), 37, André Cavalcanti Street, Rio de Janeiro (RJ), 20231-050, Brazil.
Oswaldo Cruz Foundation, National School of Public Health Sérgio Arouca, Department of Health Administration and Planning, 1480 Leopoldo Bulhões Street, Manguinhos, Rio de Janeiro (RJ), 21041-210, Brazil.
J Cancer Policy. 2021 Dec;30:100302. doi: 10.1016/j.jcpo.2021.100302. Epub 2021 Aug 21.
Cancer research is a prominent theme on national and international development agendas. In many developed countries, funding for this area comes mainly from government sources. This article analyzes government funding of cancer research in Brazil, identifying the main funding instruments and examining the regional distribution of resources, research project and researcher profiles.
Exploratory study of government funding of cancer research in Brazil between 2007 and 2016. The primary data were federal and state funding agencies.
A total of 8565 research awards were identified for the period 2007-2016. Amounting to almost US$489 million, these awards were linked to 7622 research projects and 3068 researchers. The proportion of grants awarded to women was slightly higher. It is noteworthy that just 3% of researchers received 20 % of the grants. The multiple-grant history of individual researchers seemed to be a conditioning factor for obtaining new grants/fellowships. Funding was highly concentrated in the Southeast region, accounting for 84.4 % of total awards. There was a positive correlation between number of awards and amount awarded. The most frequently studied cancers were breast (11.8 %), head and neck (9.0 %) and skin cancer (5.3 %). Studies that did not specify the type of cancer accounted for 36.8 % of grants and 45.1 % of funding.
The findings show a fall in the share of cancer research funding in the three largest funders. Cuts in government spending triggered by the country's political and economic crisis, highlight the vulnerability of science and technology. Greater transparency through access to information on funding, researcher, and research profiles is key to obtaining a better understanding the cancer research funding landscape in Brazil and reducing regional inequalities.
A more centralized management of public cancer research funding and constant investment and monitoring is needed to ensure the effective implementation of funding policy.
癌症研究是国家和国际发展议程上的一个突出主题。在许多发达国家，该领域的资金主要来自政府来源。本文分析了巴西政府对癌症研究的资助情况，确定了主要的资助工具，并考察了资源、研究项目和研究人员的地域分布情况。
对 2007 年至 2016 年巴西政府癌症研究资助进行了探索性研究。主要数据来源是联邦和州政府资助机构。
在 2007 年至 2016 年期间，共确定了 8565 项研究奖。这些奖项共计约 4.89 亿美元，与 7622 个研究项目和 3068 名研究人员相关联。授予女性的拨款比例略高。值得注意的是，只有 3%的研究人员获得了 20%的拨款。单个研究人员的多次获得拨款的历史似乎是获得新拨款/奖学金的一个制约因素。资金高度集中在东南部，占总拨款的 84.4%。拨款数量与拨款金额之间存在正相关关系。研究最多的癌症是乳腺癌（11.8%）、头颈部癌症（9.0%）和皮肤癌（5.3%）。未指明癌症类型的研究占拨款的 36.8%，占资金的 45.1%。
研究结果表明，在三个最大的资助者中，癌症研究资金的份额有所下降。该国政治和经济危机引发的政府支出削减凸显了科学技术的脆弱性。通过获取有关资金、研究人员和研究人员概况的信息来提高透明度，是更好地了解巴西癌症研究资助情况并减少区域不平等的关键。
需要更集中地管理公共癌症研究资金，并不断投资和监测，以确保有效执行资助政策。
